Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2278-2283

  Kajiyama, Hiroaki ^a   Kikkawa, Fumitaka ^a   Khin, EiEi ^a   Shibata, Kiyosumi ^a   Ino, Kazuhiko ^a   Mizutani, Shigehiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; DIPEPTIDYL PEPTIDASE IV; GELATINASE A; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR MARKER; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS POTENTIAL; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIGENS, CD26; CADHERINS; DOWN-REGULATION; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0038713433     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Heike, M., Mobius, U., Knuth, A., Meuer, S., and Meyer zum Buschenfelde, K. H. Tissue distribution of the T cell activation antigen Ta1. Serological, immunohistochemical and biochemical investigations. Clin. Exp. Immunol., 74: 431-434, 1988.
2. Nemoto, E., Sugawara, S., Takada, H., Shoji, S., and Horiuch, H. Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components. Infect. Immun., 67: 6225-6233, 1999.
3. Mizutani, S., Sumi, S., Narita, O., and Tomoda, Y. Purification and properties of human placental dipeptidyl peptidase IV. Nippon Sanka Fujinka Gakkai Zasshi, 37: 769-775, 1985.
4. Fleischer, B. CD26: a surface protease involved in T-cell activation. Immunol. Today, 15: 180-184, 1994.
5. Morimoto, C., Lord, C. I., Zhang, C., Duke-Cohan, J. S., Letvin, N. L., and Schlossman, S. F. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl. Acad. Sci. USA, 91: 9960-9964, 1994.
6. Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E., and Norcross, M. A. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med., 186: 1865-1872, 1997.
7. Yaron, A., and Naider, F. Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol., 28: 31-81, 1993.
8. Hanski, C., Huhle, T., and Reutter, W. Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen. Biol. Chem. Hoppe-Seyler, 366: 1169-1176, 1985.
9. Loster, K., Zeilinger, K., Schuppan, D., and Reutter, W. The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem. Biophys. Res. Commun., 217: 341-348, 1995.
10. Gaetaniello, L., Fiore, M., de Filippo, S., Pozzi, N., Tamasi, S., and Pignata, C. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells. Hepatology, 27: 934-942, 1998.
11. Cheng, H. C., Abdel-Ghany, M., Elble, R. C., and Pauli, B. U. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J. Biol. Chem., 273: 24207-24215, 1998.
12. Pethiyagoda, C. L., Welch, D. R., and Fleming, T. P. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin. Exp. Metastasis, 18: 391-400, 2000.
13. 2/M checkpoint. Cancer Res., 61: 7204-7210, 2001.
14. Wesley, U. V., Albino, A. P., Tiwari, S., and Houghton, A. N. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J. Exp. Med., 190: 311-322, 1999.
15. Kajiyama, H., Kikkawa, F., Suzuki, T., Shibata, K., Ino, K., and Mizutani, S. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res., 62: 2753-2757, 2002.
16. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science (Wash. DC), 251: 1451-1455, 1991.
17. Davidson, B., Gotlieb, W. H., Ben-Baruch, G., Nesland, J. M., Bryne, M., Goldberg, I., Kopolovic, J., and Berner, A. E-Cadherin complex protein expression and survival in ovarian carcinoma. Gynecol. Oncol., 79: 362-371, 2000.
18. Conacci-Sorrell, M., Zhurinsky, J., and Ben-Ze'ev, A. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Investig., 109: 987-991, 2002.
19. Takeichi, M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol., 5: 806-811, 1993.
20. Luo, J., Lubaroff, D. M., and Hendrix, M. J. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res., 59: 3552-3556, 1999.
21. Ara, T., Deyama, Y., Yoshimura, Y., Higashino, F., Shindoh, M., Matsumoto, A., and Fukuda, H. Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade. Cancer Lett., 157: 115-121, 2000.
22. Suzuki, T., Kikkawa, F., Ino, K., Nagasaka, T., Tamakoshi, K., and Mizutani, S. Imbalance between neutral endopeptidase 24.11 and endothelin-1 expression in human endometrial carcinoma. Oncology (Basel), 60: 258-267, 2001.
23. r 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines. Cancer Res., 57: 5416-5420, 1997.
24. Yano, T., and Yamasaki, H. Regulation of cellular invasion and matrix metalloproteinase activity in HepG2 cell by connexin 26 transfection. Mol. Carcinog., 31: 101-109, 2001.
25. Ho, A. T., Voura, E. B., Soloway, P. D., Watson, K. L., and Khokha, R. MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function. J. Biol. Chem., 276: 40215-40224, 2001.
26. Kikkawa, F., Tamakoshi, K., Nawa, A., Shibata, K., Yamagata, S., Yamagata, T., and Suganuma, N. Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues. Cancer Lett., 120: 109-115, 1997.
27. Shih Ie, M., Hsu, M. Y., Oldt, R. J., III, Herlyn, M., Gearhart, J. D., and Kurman, R. J. The role of E-cadherin in the motility and invasion of implantation site intermediate trophoblast. Placenta, 23: 706-715, 2002.
28. Sato, Y., Fujiwara, H., Higuchi, T., Yoshioka, S., Tatsumi, K., Maeda, M., and Fujii, S. Involvement of dipeptidyl peptidase IV in extravillous trophoblast invasion and differentiation. J. Clin. Endocrinol. Metab., 87: 4287-4296, 2002.
29. Floridon, C., Nielsen, O., Holund, B., Sunde, L., Westergaard, J. G., Thomsen, S. G., and Teisner, B. Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy. Mol. Hum. Reprod., 6: 943-950, 2000.
30. Mentlein, R. Dipeptidyl-peptidase IV (CD26): role in the inactivation of regulatory peptides. Regul. Pept., 85: 9-24, 1999.
31. Pece, S., and Gutkind, J. S. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J. Biol. Chem., 275: 41227-41233, 2000.
32. Lu, Q., Paredes, M., Zhang, J., and Kosik, K. S. Basal extracellular signal-regulated kinase activity modulates cell-cell and cell-matrix interactions. Mol. Cell. Biol., 18: 3257-3265, 1998.
33. Furuyama, H., Arii, S., Mori, A., and Imamura, M. Role of E-cadherin in peritoneal dissemination of the pancreatic cancer cell line, panc-1, through regulation of cell to cell contact. Cancer Lett., 157: 201-209, 2000.
34. Wilding, J., Vousden, K. H., Soutter, W. P., McCrea, P. D., Del Buono, R., and Pignatelli, M. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Cancer Res., 56: 5285-5292, 1996.